A Randomised, Open-Label, Phase I Study to Determine the Effect of Food on the Pharmacokinetics of Oral AZD8931 Tablets in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 09 Dec 2009
At a glance
- Drugs Sapitinib (Primary)
- Indications Solid tumours
- Focus Pharmacokinetics
- 24 Oct 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 26 Jun 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 20 May 2009 Additional lead trial investigator (Stuart M) identified as reported by ClinicalTrials.gov.